CRISPR Technology — Revision Notes

⚡ 30-Second Revision

CRISPR-Cas9: — Bacterial immune system repurposed for gene editing.
Components: — Guide RNA (target), Cas9 enzyme (cut), PAM (recognition).
Repair: — NHEJ (knockout, error-prone), HDR (correction/insertion, precise).
CRISPR 2.0: — Base Editing (single base change, no DSB), Prime Editing (all base changes, small indels, no DSB).
Applications: — Gene therapy (SCD, thalassemia), agriculture (disease/stress resistance), diagnostics (SHERLOCK).
Ethics: — Somatic editing permitted (ICMR), Germline editing prohibited (ICMR, global consensus).
Nobel Prize: — 2020 Chemistry to Doudna & Charpentier.

2-Minute Revision

CRISPR-Cas9 is a revolutionary gene-editing tool derived from bacterial immunity, allowing precise DNA modification. It comprises a guide RNA (gRNA) that directs the Cas9 enzyme to a specific DNA target, recognized by a Protospacer Adjacent Motif (PAM).

Cas9 then creates a double-strand break (DSB). Cells repair this break via Non-Homologous End Joining (NHEJ), which is error-prone and leads to gene inactivation, or Homology-Directed Repair (HDR), which is precise and enables gene correction or insertion using a template.

This technology has vast applications: in medicine for treating genetic disorders like sickle cell disease, in agriculture for developing disease-resistant and climate-resilient crops (e.g., in India), and in diagnostics for rapid pathogen detection.

Recent advancements, termed 'CRISPR 2.0,' include Base Editing and Prime Editing, which offer enhanced precision by making specific base changes or small insertions/deletions without creating DSBs, thereby reducing off-target effects.

Ethically, while somatic cell gene therapy is permitted under strict Indian (ICMR) and global guidelines, germline gene editing (heritable changes) remains prohibited due to profound ethical and safety concerns, as highlighted by the He Jiankui controversy.

Understanding CRISPR requires appreciating its scientific elegance, its transformative potential, and the critical ethical and regulatory frameworks governing its responsible use.

5-Minute Revision

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is a groundbreaking gene-editing system, repurposed from a bacterial adaptive immune mechanism. Its core components are the Cas9 enzyme, acting as molecular scissors, and a guide RNA (gRNA), which directs Cas9 to a specific DNA sequence.

The Cas9 enzyme's binding and cleavage are contingent on the presence of a Protospacer Adjacent Motif (PAM) sequence adjacent to the target. Once a double-strand break (DSB) is created, the cell's natural repair pathways are exploited: Non-Homologous End Joining (NHEJ) is an error-prone pathway leading to gene knockout, while Homology-Directed Repair (HDR) is a precise pathway used for gene correction or insertion when a template is provided.

This precision, cost-effectiveness, and ease of use make CRISPR superior to older gene-editing tools like ZFNs and TALENs.

CRISPR's applications are diverse and impactful. In medicine, it holds immense promise for gene therapy, targeting monogenic disorders such as sickle cell disease and beta-thalassemia (e.g., CTX001 trials).

It's also being explored for cancer immunotherapies and treating infectious diseases. In agriculture, CRISPR is revolutionizing crop improvement, enabling the development of disease-resistant (e.g., rice blast), stress-tolerant (drought, salinity), and nutritionally enhanced varieties, with significant research in India by institutions like IARI and NIPGR.

Beyond editing, CRISPR-based diagnostics (e.g., SHERLOCK, DETECTR) offer rapid and sensitive detection of pathogens. Recent 'CRISPR 2.0' innovations, such as Base Editing (single base changes without DSBs) and Prime Editing (all base changes, small insertions/deletions without DSBs), further enhance precision and expand the range of correctable mutations.

Ethical and regulatory considerations are paramount. India, through ICMR guidelines, permits somatic cell gene therapy under strict oversight but strictly prohibits germline gene editing due to irreversible, inheritable changes and profound ethical concerns.

This aligns with global consensus from WHO and UNESCO, reinforced by the He Jiankui controversy. Regulatory frameworks for gene-edited crops are evolving, with India's MoEFCC recently exempting certain categories from stringent GMO rules.

Understanding CRISPR requires a holistic view, balancing its immense potential for human welfare and sustainable development with the critical need for robust ethical governance and public engagement to ensure responsible innovation.

Prelims Revision Notes

CRISPR Definition: — Clustered Regularly Interspaced Short Palindromic Repeats. A gene-editing tool derived from bacterial immunity.
Key Components:

- Cas9 Enzyme: Molecular scissors, cuts DNA. - Guide RNA (gRNA): Directs Cas9 to specific DNA target via base pairing. - PAM (Protospacer Adjacent Motif): Short DNA sequence (e.g., NGG) essential for Cas9 binding and cleavage, located next to target.

DNA Repair Pathways:

- NHEJ (Non-Homologous End Joining): Error-prone, ligates broken ends, often causes indels, leads to gene 'knockout' (inactivation). - HDR (Homology-Directed Repair): Precise, uses homologous template to repair, leads to gene 'correction' or 'insertion'. Less efficient than NHEJ.

CRISPR 2.0 Variants:

- Base Editing: Converts one base to another (e.g., C to T, A to G) without creating a double-strand break (DSB). Ideal for point mutations. - Prime Editing: More versatile, can make all 12 base changes, small insertions/deletions, also without DSBs. Uses Cas9 nickase + reverse transcriptase.

Applications:

- Therapeutic: Sickle cell disease, beta-thalassemia (CTX001), cancer immunotherapy (CAR-T), inherited blindness (EDIT-101). - Agricultural: Disease resistance (rice blast, wheat powdery mildew), stress tolerance (drought, salinity), nutritional enhancement (e.g., Indian mustard projects). - Diagnostics: SHERLOCK, DETECTR (rapid pathogen detection, e.g., COVID-19). - Gene Drives: Controversial, for population control (e.g., mosquitoes).

Ethical & Regulatory (India):

- ICMR Guidelines: Somatic cell gene therapy permitted; Germline gene therapy prohibited. - DBT/MoEFCC: Regulate gene-edited crops; MoEFCC 2022 notification exempts SDN-1/2 from stringent GMO rules.

Nobel Prize: — 2020 Chemistry to Jennifer Doudna and Emmanuelle Charpentier for CRISPR-Cas9 development.
Limitations: — Off-target effects, mosaicism, delivery challenges, immunogenicity.

Mains Revision Notes

Introduction: — Define CRISPR as a precise gene-editing tool, a paradigm shift in biotechnology, with dual potential and challenges.
Mechanism (Brief): — RNA-guided Cas9 cleavage, PAM, DSB, NHEJ (knockout) vs. HDR (correction). Mention CRISPR 2.0 (Base/Prime editing) for enhanced precision without DSBs.
Transformative Potential (India-centric):

- Healthcare: Gene therapy for prevalent genetic disorders (sickle cell, thalassemia), personalized medicine, affordable diagnostics for infectious diseases (TB, dengue). Emphasize accessibility.

- Agriculture: Food security through climate-resilient (drought/salinity tolerant) and disease-resistant crops (e.g., rice, mustard). Increased yield, reduced pesticide use. Reference ICAR, NIPGR, DBT initiatives, MoEFCC 2022 notification.

- Research: Fundamental biological understanding, drug discovery.

Ethical Dilemmas:

- Germline Editing: ICMR prohibition, global consensus (WHO, UNESCO), irreversible changes, 'designer babies,' human dignity. He Jiankui controversy as a case study. - Equity & Access: Who benefits? Affordability of therapies, potential for exacerbating health disparities. - Biosafety: Unforeseen ecological impacts (gene drives), off-target effects.

Regulatory Challenges (India & Global):

- Indian Framework: ICMR guidelines (human research), DBT/MoEFCC (agricultural/environmental release). Evolving classification of gene-edited products. - Global Governance: Need for international harmonization, WHO recommendations, UNESCO statements, balancing innovation with precaution. - Public Acceptance: Addressing misinformation, fostering informed public debate.

Conclusion: — Acknowledge CRISPR's immense promise. Stress the imperative for robust, adaptive, and ethically sound governance, public engagement, and international collaboration to ensure responsible and equitable deployment for India's sustainable development.

Vyyuha Quick Recall

CRISPR-CUTS:

Cas9: The molecular Cutter enzyme.
RNA: The Routing guide for Cas9.
Innovative: Immense potential for precise editing.
Safety: Scrutiny needed for off-targets and ethics.
PAM: The Positioning motif for Cas9 binding.
Repair: Routes of DNA repair (NHEJ/HDR).
Crop: Changes for better agriculture.
Understanding: Unlocks biological mysteries.
Therapy: Treatments for genetic diseases.
Social: Strong ethical and societal debates.